ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laurino, J.
Right arrow Articles by Kuhn, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laurino, J.
Right arrow Articles by Kuhn, C
Annals of Clinical and Laboratory Science, Vol 27, Issue 3, 230-235
Copyright © 1997 by Association of Clinical Scientists


Articles

An immunoassay for anti-neuronal antibodies associated with involuntary repetitive movement disorders

JP Laurino, J Hallett, LS Kiessling, M Benson, T Pelletier, and C Kuhn

Tourette's syndrome (TS) is a complex neurobehavioral disorder emerging in childhood and is characterized by motor and vocal tics of at least one year in duration. In a portion of patients with TS, environmental (non-genetic) factors may either have an etiologic role or act to modulate the phenotype. One possible environmental factor may be antibodies to central nervous system cells, as sera from several children diagnosed with either TS or Sydenham's chorea contained anti-neuronal antibodies. Using enriched membrane preparations isolated from HTB-10 neuroblastoma cells, a sensitive and specific assay was developed for the determination of human anti-neuronal antibodies associated with involuntary repetitive movement disorders. This assay exhibited between-run and within-run precision of 11.3 percent and 5.9 percent, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of this assay for the diagnosis of TS and TS or chorea are 79.1 percent, 61.2 percent, 61.6 percent, 78.8 percent, and 71.1 percent, 60.9 percent, 68.6 percent, and 63.6 percent, respectively. In addition, there was a significant difference (p < 0.0001) between the mean optical density in the patients with TS and children determined to be clinically "normal".


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
P. J. Hoekstra, J. Bijzet, P. C. Limburg, M.-P. Steenhuis, P. W. Troost, M. D. Oosterhoff, J. Korf, C. G.M. Kallenberg, and R. B. Minderaa
Elevated D8/17 Expression on B Lymphocytes, a Marker of Rheumatic Fever, Measured With Flow Cytometry in Tic Disorder Patients
Am J Psychiatry, April 1, 2001; 158(4): 605 - 610.
[Abstract] [Full Text]


Home page
BrainHome page
M. M. Robertson
Tourette syndrome, associated conditions and the complexities of treatment
Brain, March 1, 2000; 123(3): 425 - 462.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Association of Clinical Scientists.